Vita Coco Insider Sale: Kirban Disposes 20,000 Shares via 10b5-1 Plan
Rhea-AI Filing Summary
Michael Kirban, Executive Chairman and Director of Vita Coco Company, Inc. (COCO), reported transactions on 09/22/2025. He sold 20,000 shares of common stock pursuant to a Rule 10b5-1 trading plan at a weighted average price of $41.535 per share. The Form 4 shows he beneficially owns 1,529,049 shares indirectly through the Michael Kirban 2010 Trust and additional holdings reflected as direct and indirect positions. The filing also lists multiple outstanding non-qualified stock options with exercise prices from $10.178 to $32.78 and varying vesting or exercisability dates.
Positive
- None.
Negative
- None.
Insights
TL;DR: Insider sold a small block under a Rule 10b5-1 plan; sizeable indirect holdings and multiple exercisable/options remain.
The Form 4 discloses a 20,000-share disposition executed under a Rule 10b5-1 plan at a weighted average of $41.535. The reporting person retains material indirect ownership of 1,529,049 shares via the Michael Kirban 2010 Trust and holds numerous stock options across maturities and strike prices, several of which are fully vested and exercisable. From an equity-capital perspective, the filing documents routine insider liquidity rather than a change in control or debt-equity structure.
TL;DR: Disclosure is complete and notes use of an affirmative-defense trading plan; no governance actions or departures reported.
The filer explicitly states the sale was made pursuant to a Rule 10b5-1 trading plan and provides weighted-average pricing ranges, which supports procedural transparency. The Form 4 identifies the reporting person as both Executive Chairman and a director and documents indirect ownership via trusts and multiple option grants with vesting schedules. There are no disclosed resignations, new appointments, or governance events in this filing.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 20,000 | $41.535 | $831K |
| holding | Non-Qualified Stock Option (right to buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (right to buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (right to buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (right to buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (right to buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (right to buy) | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.50 to $41.60, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. These shares are held by the Michael Kirban 2010 Trust. These shares are held by the Michael Kirban Revocable Trust. The stock option is fully vested and currently exercisable. The stock option is fully vested and currently exercisable. The stock option vests in four equal annual installments beginning on November 27, 2022. The stock option vests in four equal annual installments beginning on March 10, 2024. The stock option vests in four equal annual installments beginning on March 4, 2025. The Stock Option vests in four equal annual installments beginning in March 3, 2026.
